1-4 of 4
Sirkku Jyrkkiö
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy

Free
Francesco d'Amore, Sirpa Leppä, Maria Gomes da Silva, Thomas Relander, Peter De Nully Brown, Eckhart Weidmann, Grete Fossum Lauritzsen, Antonio Pezzutto, Achiel Van Hoof, Michel van Gelder, Jeanette K Doorduijn, Ka Lung Wu, MD, PhD, J.C. Kluin-Nelemans, P.J. Lugtenburg, Milada Jankovska, Mats Merup, Unn-Merete Fagerli, Jan Walewski, Hans Hagberg, Jose Mario Mariz, Per Boye Hansen, Thomas Nösslinger, Ann Janssens, Lena Brandefors, Hilde Demuynck, Martyn Ronald Schaafsma, Ilse Christiansen, David Salek, Sirkku Jyrkkiö, Vit Prochazka, Josee Zijlstra, L. Böhmer, Richard Greil, MD, Wendy Stevens, Rob Fijnheer, Marinus van Marwijk Kooy, Matthias Grube, Georg Hopfinger, MD, Eric Van den Neste, Esa Jantunen, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Helle Toldbod
Journal: Blood
Blood (2012) 120 (21): 57.
https://doi.org/10.1182/blood.V120.21.57.57
Published: 2012
Journal Articles

First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,

Free
Francesco d'Amore, MD, DMSci, Maria Gomes da Silva, Sirpa Leppa, Thomas Relander, Antonio Pezzutto, Grete F. Lauritzsen, Eckhart Weidmann, Michel Van Gelder, Mats Merup, Hans Hagberg, Unn-Merete Fagerli, Peter de Nully Brown, Per Boye Hansen, Jose Mario Mariz, Milada Jankovska, Jan Walewski, MD, PhD, Jeanette Doorduijn, Achiel Van Hoof, Ilse Christiansen, Sirkku Jyrkkiö, J.C. Kluin-Nelemans, Marinus van Marwijk Kooy, Rob Fijnheer, Wendy Stevens, Josee Zijlstra, L. Böhmer, P.J. Lugtenburg, Matthias Grube, Vit Prochazka, David Salek, Richard Greil, MD, Lorenz Trümper, Gerald Wulf, Bettina Altmann, Marita Ziepert, Markus Loeffler, Esa Jantunen, Georg Hopfinger, Eric Van den Neste, MD, Helle Toldbod
Journal: Blood
Blood (2011) 118 (21): 4110.
https://doi.org/10.1182/blood.V118.21.4110.4110
Published: 2011
Journal Articles

R-CHOEP-14 × 6 Followed by Systemic CNS Prophylaxis for Diffuse Large B-Cell Lymphoma/Follicular Lymphoma Grade 3 with Age Adjusted IPI Score 2–3: Final Results of a Nordic Lymphoma Group Phase 2 Study Including 156 Patients Aged 18–65 Years.

Free
Harald Holte, MD, PhD, Sirpa Leppä, MD, PhD, Magnus Bjorkholm, MD, PhD, Øystein Fluge, MD, PhD, Sirkku Jyrkkiö, MD, PhD, Jan Delabie, MD, PhD, Christer Sundstrom, MD, PhD, Marja-Liisa Karjalainen-Lindsberg, Martin Erlanson, MD, PhD, Arne Kolstad, MD, PhD, Alexander Fosså, MD, PhD, Bj∅rn Østenstad, MD, PhD, Eva Löfvenberg, MD, Marie Nordström, MD, PhD, Lars Möller Pedersen, MD, PhD, Harald Anderson, PhD, Mats Jerkeman, MD, PhD, Mikael Eriksson, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2805.
https://doi.org/10.1182/blood.V116.21.2805.2805
Published: 2010
Journal Articles

Elderly Patients with Mantle Cell Lymphoma (MCL) – Efficacy and Feasibility of Prolonged Immunochemotherapy with Rituximab, Cytarabine and Fludarabine Added to CHOP and Followed by Rituximab Maintenance Treatment. A Prospective Study by the Finnish Lymphoma Group

Free
Erkki Elonen, Riikka Räty, Tuomo Honkanen, Esa Jantunen, Sirkku Jyrkkiö, Marja-Liisa Karjalainen-Lindsberg, Outi Kuittinen, Minna Lehto, Eira Poikonen, Auvo Rauhala, Johanna Rimpiläinen, Anu Räsänen, Sanna Siitonen, Merja Suominen, Mirja Vapaatalo
Journal: Blood
Blood (2008) 112 (11): 1001.
https://doi.org/10.1182/blood.V112.11.1001.1001
Published: 2008